−0.53 EUR
−5.08 M EUR
9.05 M EUR
4.16 M
About AELIS FARMA
Sector
Industry
CEO
Pier Vincenzo Piazza
Website
Headquarters
Bordeaux
Founded
2013
ISIN
FR0014007ZB4
FIGI
BBG01522XLZ9
Aelis Farma SA is a biopharmaceutical company. It engages in the business of researching and developing pharmaceutical products. The company was founded by Valérie Scappaticci and Pier Vincenzo Piazza on October 7, 2013 and is headquartered in Bordeaux, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AELIS is 2.04 EUR — it has increased by 2.00% in the past 24 hours. Watch AELIS FARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange AELIS FARMA stocks are traded under the ticker AELIS.
AELIS stock has fallen by −1.92% compared to the previous week, the month change is a −25.55% fall, over the last year AELIS FARMA has showed a −84.55% decrease.
We've gathered analysts' opinions on AELIS FARMA future price: according to them, AELIS price has a max estimate of 14.20 EUR and a min estimate of 4.00 EUR. Watch AELIS chart and read a more detailed AELIS FARMA stock forecast: see what analysts think of AELIS FARMA and suggest that you do with its stocks.
AELIS reached its all-time high on Feb 18, 2022 with the price of 14.48 EUR, and its all-time low was 1.90 EUR and was reached on Dec 23, 2024. View more price dynamics on AELIS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AELIS stock is 0.00% volatile and has beta coefficient of 0.73. Track AELIS FARMA stock price on the chart and check out the list of the most volatile stocks — is AELIS FARMA there?
Yes, you can track AELIS FARMA financials in yearly and quarterly reports right on TradingView.
AELIS net income for the last half-year is −3.58 M EUR, while the previous report showed −3.44 M EUR of net income which accounts for −4.01% change. Track more AELIS FARMA financial stats to get the full picture.
No, AELIS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 24.00 employees. See our rating of the largest employees — is AELIS FARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AELIS FARMA EBITDA is −10.67 M EUR, and current EBITDA margin is −106.00%. See more stats in AELIS FARMA financial statements.
Like other stocks, AELIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AELIS FARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AELIS FARMA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AELIS FARMA stock shows the sell signal. See more of AELIS FARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.